Literature DB >> 29705836

Commentary on: A cost-effectiveness analysis of onabotulinumtoxin A as first-line treatment for overactive bladder.

Abdelmageed Abdelrahman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29705836     DOI： 10.1007/s00192-018-3662-y

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN： 0937-3462            Impact factor:   2.894


× No keyword cloud information.
  1 in total

1.  A cost-effectiveness analysis of Onabotulinumtoxin A as first-line treatment for overactive bladder.

Authors:  Jonathan P Shepherd; Charelle M Carter-Brooks; Christopher Chermanksy
Journal:  Int Urogynecol J       Date:  2018-04-18       Impact factor: 2.894
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.